Product NDC: | 0603-1588 |
Proprietary Name: | Promethazine VC With Codeine |
Non Proprietary Name: | Codeine Phosphate, Promethazine Hydrochloride, and Phenylephrine Hydrochloride |
Active Ingredient(s): | 10; 5; 6.25 mg/5mL; mg/5mL; mg/5mL & nbsp; Codeine Phosphate, Promethazine Hydrochloride, and Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0603-1588 |
Labeler Name: | Qualitest Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040660 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061207 |
Package NDC: | 0603-1588-56 |
Package Description: | 237 mL in 1 BOTTLE (0603-1588-56) |
NDC Code | 0603-1588-56 |
Proprietary Name | Promethazine VC With Codeine |
Package Description | 237 mL in 1 BOTTLE (0603-1588-56) |
Product NDC | 0603-1588 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Codeine Phosphate, Promethazine Hydrochloride, and Phenylephrine Hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20061207 |
Marketing Category Name | ANDA |
Labeler Name | Qualitest Pharmaceuticals |
Substance Name | CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE |
Strength Number | 10; 5; 6.25 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |